INTRODUCTION: This study was done to further reveal the role of the innate immune system in celiac disease. METHODS: Dendritic cells were matured from venous blood of patients with active or treated celiac disease and DQ2-DQ8-positive or negative controls. Dendritic cells were treated with a peptic-tryptic digest of gliadin (500 microg/ml) and their activation was analyzed by fluorescent-activated cell sorting analysis, cytokine secretion, and their ability to elicit T cell proliferation. RESULTS AND DISCUSSION: Gliadin upregulated interleukin (IL)-6, IL-8, and IL-12 (p40) secretion in dendritic cells and induced strong expression of the maturation markers human leukocyte antigen (HLA)-DR, CD25, CD83, and CD86 of all subjects irrespective of their genotype or the presence of disease, whereas the digest of bovine serum albumin showed no effect. However, gliadin-stimulated dendritic cells from active celiac showed enhanced stimulation of autologous T cells compared to the other groups. CONCLUSION: Further research should be aimed at identifying the mechanisms that control inflammation in healthy individuals.
INTRODUCTION: This study was done to further reveal the role of the innate immune system in celiac disease. METHODS: Dendritic cells were matured from venous blood of patients with active or treated celiac disease and DQ2-DQ8-positive or negative controls. Dendritic cells were treated with a peptic-tryptic digest of gliadin (500 microg/ml) and their activation was analyzed by fluorescent-activated cell sorting analysis, cytokine secretion, and their ability to elicit T cell proliferation. RESULTS AND DISCUSSION: Gliadin upregulated interleukin (IL)-6, IL-8, and IL-12 (p40) secretion in dendritic cells and induced strong expression of the maturation markers human leukocyte antigen (HLA)-DR, CD25, CD83, and CD86 of all subjects irrespective of their genotype or the presence of disease, whereas the digest of bovine serum albumin showed no effect. However, gliadin-stimulated dendritic cells from active celiac showed enhanced stimulation of autologous T cells compared to the other groups. CONCLUSION: Further research should be aimed at identifying the mechanisms that control inflammation in healthy individuals.
Authors: Jana Cinova; Lenka Palová-Jelínková; Lesley E Smythies; Marie Cerná; Barbara Pecharová; Milos Dvorák; Pavel Fruhauf; Helena Tlaskalová-Hogenová; Phillip D Smith; Ludmila Tucková Journal: J Clin Immunol Date: 2007-01-27 Impact factor: 8.317
Authors: Carlo Catassi; Deborah Kryszak; Otto Louis-Jacques; Donald R Duerksen; Ivor Hill; Sheila E Crowe; Andrew R Brown; Nicholas J Procaccini; Brigid A Wonderly; Paul Hartley; James Moreci; Nathan Bennett; Karoly Horvath; Margaret Burk; Alessio Fasano Journal: Am J Gastroenterol Date: 2007-03-13 Impact factor: 10.864
Authors: K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid Journal: J Exp Med Date: 1993-07-01 Impact factor: 14.307
Authors: Francisco Cabrera-Chávez; Stefania Iametti; Matteo Miriani; Ana M Calderón de la Barca; Gianfranco Mamone; Francesco Bonomi Journal: Plant Foods Hum Nutr Date: 2012-03 Impact factor: 3.921
Authors: Barbara Chladkova; Jana Kamanova; Lenka Palova-Jelinkova; Jana Cinova; Peter Sebo; Ludmila Tuckova Journal: J Cell Mol Med Date: 2011-04 Impact factor: 5.310
Authors: Yvonne Junker; Sebastian Zeissig; Seong-Jun Kim; Donatella Barisani; Herbert Wieser; Daniel A Leffler; Victor Zevallos; Towia A Libermann; Simon Dillon; Tobias L Freitag; Ciaran P Kelly; Detlef Schuppan Journal: J Exp Med Date: 2012-12-03 Impact factor: 14.307
Authors: Camilla Salvestrini; Mark Lucas; Paolo Lionetti; Franco Torrente; Sean James; Alan D Phillips; Simon H Murch Journal: PLoS One Date: 2014-09-08 Impact factor: 3.240